Frequent promoter hypermethylation and transcriptional downregulation of BTG4 gene in gastric cancer

Biochemical and Biophysical Research Communications

Volumn 387, Issue 1, 2009, Pages 132-138

  Dong, Wenjie ^a   Tu, Shuiping ^b   Xie, Jing ^a   Sun, Pinghu ^a   Wu, Yunlin ^a   Wang, Lifu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Columbia University ^*  (United States)

Author keywords

BTG4; Gastric cancer; Hypermethylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; GENOMIC DNA; RNA;

ARTICLE; BTG4 GENE; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMOSOME 11Q; CONTROLLED STUDY; DNA METHYLATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE MAPPING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH MUCOSA; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; MICE, INBRED BALB C; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 67651008220     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.06.140     Document Type: Article

References (22)

1. Tirone F. The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?. J. Cell. Physiol. 187 (2001) 155-165
2. Rouault J.P., Falette N., Guehenneux F., Guillot C., Rimokh R., Wang Q., Berthet C., Moyret-Lalle C., Savatier P., Pain B., Shaw P., Berger R., Samarut J., Magaud J.P., Ozturk M., Samarut C., and Puisieux A. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14 (1996) 482-486
3. Boiko A.D., Porteous S., Razorenova O.V., Krivokrysenko V.I., Williams B.R., and Gudkov A.V. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev. 20 (2006) 236-252
4. Ou Y.H., Chung P.H., Hsu F.F., Sun T.P., Chang W.Y., and Shieh S.Y. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. Embo J. 26 (2007) 3968-3980
5. Toyota M., Suzuki H., Sasaki Y., Maruyama R., Imai K., Shinomura Y., and Tokino T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 68 (2008) 4123-4132
6. Tu S.P., Jiang X.H., Lin M.C., Cui J.T., Yang Y., Lum C.T., Zou B., Zhu Y.B., Jiang S.H., Wong W.M., Chan A.O., Yuen M.F., Lam S.K., Kung H.F., and Wong B.C. Suppression of surviving expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res. 63 (2003) 7724-7732
7. Kim J.S., Kim H., Shim Y.M., Han J., Park J., and Kim D.H. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 25 (2004) 2165-2171
8. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826
9. Abbaszadegan M.R., Moaven O., Sima H.R., Ghafarzadegan K., A'Rabi A., Forghani M.N., Raziee H.R., Mashhadinejad A., Jafarzadeh M., Esmaili-Shandiz E., and Dadkhah E. P16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer. World J. Gastroenterol. 14 (2008) 2055-2060
10. Dong C.X., Deng D.J., Pan K.F., Zhang L., Zhang Y., Zhou J., and You W.C. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a population-based study. Int. J. Cancer 124 (2009) 434-439
11. Dammann R., Schagdarsurengin U., Strunnikova M., Rastetter M., Seidel C., Liu L., Tommasi S., and Pfeifer G.P. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol. Histopathol. 18 (2003) 665-677
12. Sato K., Tamura G., Tsuchiya T., Endoh Y., Usuba O., Kimura W., and Motoyama T. Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br. J. Cancer 85 (2001) 199-203
13. Choi S.C., Kim K.D., Kim J.T., Kim J.W., Lee H.G., Kim J.M., Jang Y.S., Yoon D.Y., Kim K.I., Yang Y., Cho D.H., and Lim J.S. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity. J. Leukoc. Biol. 83 (2008) 89-98
14. Buffart T.E., Overmeer R.M., Steenbergen R.D., Tijssen M., van Grieken N.C., Snijders P.J., Grabsch H.I., van de Velde C.J., Carvalho B., and Meijer G.A. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer. Br. J. Cancer 99 (2008) 1802-1807
15. David S., Kan T., Cheng Y., Agarwal R., Jin Z., and Mori Y. Aberrant silencing of the endocrine peptide gene tachykinin-1 in gastric cancer. Biochem. Biophys. Res. Commun. 378 (2009) 605-609
16. Auer R.L., Starczynski J., McElwaine S., Bertoni F., Newland A.C., Fegan C.D., and Cotter F.E. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia. Genes Chromosomes Cancer 43 (2005) 1-10
17. Hampton G.M., Mannermaa A., Winqvist R., Alavaikko M., Blanco G., Taskinen P.J., Kiviniemi H., Newsham I., Cavenee W.K., and Evans G.A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res. 54 (1994) 4586-4589
18. Carter S.L., Negrini M., Baffa R., Gillum D.R., Rosenberg A.L., Schwartz G.F., and Croce C.M. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res. 54 (1994) 6270-6274
19. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G.N., Hirohashi S., and Croce C.M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56 (1996) 268-272
20. Rasio D., Negrini M., Manenti G., Dragani T.A., and Croce C.M. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res. 55 (1995) 3988-3991
21. Tomlinson I.P., and Bodmer W.F. Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis. J. Clin. Pathol. 49 (1996) 386-390
22. Herbst R.A., Larson A., Weiss J., Cavenee W.K., Hampton G.M., and Arden K.C. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res. 55 (1995) 2494-2496